ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

CARLOS RODRIGUEZ GOMEZ M.D.

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,952Medicare Part D Prescriptions Filled, Including Refills

Rank: 133 out of 1479

$379K Total Retail Price of All Prescriptions

Rank: 100 out of 1479

427 Patients Receiving at Least One Drug in Part D
56%Patients 65 Years and Older
3% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Puerto Rico
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 427 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

2% of this provider’s 5,903 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$38 was the average price of a prescription from this provider, compared to $33 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Puerto Rico
SIMVASTATIN 568 372 1 1
RANITIDINE HCL 476 264 2 4
METFORMIN HCL 373 186 3 2
ENALAPRIL MALEATE 373 233 3 3
AMLODIPINE BESYLATE 302 180 5 6
GABAPENTIN 301 159 6 5
OMEPRAZOLE 293 134 7 7
LISINOPRIL 280 107 8 16
SYNTHROID 229 113 9 12
TRAMADOL HCL 208 107 10 20
DONEPEZIL HCL 196 196 11 45
HYDROCHLOROTHIAZIDE 181 104 12 10
LEVOTHYROXINE SODIUM 175 135 13 9
FUROSEMIDE 161 131 14 15
ATENOLOL 156 86 15 11
GLIPIZIDE 138 78 16 13
INSULIN SYRINGE 126 74 17 30
NAMENDA 124 124 18 69
NABUMETONE 117 47 19 22
ORPHENADRINE CITRATE 110 22 R 20 118
PENTOXIFYLLINE 106 70 21 40
LOSARTAN POTASSIUM 105 67 22 8
HUMULIN N 100 76 23 42
METOPROLOL TARTRATE 95 43 24 17
BETAMETHASONE DIPROPIONATE 88 42 25 91
MECLIZINE HCL 84 54 26 50
DOXAZOSIN MESYLATE 83 28 27 33
ZOLPIDEM TARTRATE 82 68 28 23
GLYBURIDE MICRONIZED 78 41 R 29 72
DIOVAN 78 60 29 85
GEMFIBROZIL 73 33 31 49
AZITHROMYCIN 68 27 32 25
CLOPIDOGREL 68 52 32 46
HUMULIN 70-30 65 35 34 43
SERTRALINE HCL 65 64 34 38
FLUOXETINE HCL 64 36 36 76
CAPTOPRIL 63 35 37 28
ETODOLAC 63 32 37 75
ALENDRONATE SODIUM 62 53 39 19
CLOTRIMAZOLE-BETAMETHASONE 60 39 40 39
LOSARTAN-HYDROCHLOROTHIAZIDE 58 42 41 14
LANTUS 56 35 42 35
METOCLOPRAMIDE HCL 56 38 42 127
DICLOFENAC POTASSIUM 55 25 44 29
KETOCONAZOLE 54 20 45 93
ISOSORBIDE MONONITRATE ER 52 39 46 31
PLAVIX 52 33 46 52
TRAMADOL HCL-ACETAMINOPHEN 51 30 48 18
SINGULAIR 51 20 48 74
CARVEDILOL 50 43 50 32
OXYCODONE-ACETAMINOPHEN 50 11 S2 50 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 2, 2012.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.